Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study (Q44671788)

5 December 2017

title

Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study (English)

1 reference

5 December 2017

0 references

1 reference

1 reference

1 reference

1 reference

6

Tommaso Stroffolini

1 reference

5 December 2017

8

Mario Rizzetto

1 reference

5 December 2017

Giovanni B Gaeta

1

1 reference

5 December 2017

Gianfranca Stornaiuolo

2

1 reference

5 December 2017

Davide F Precone

3

1 reference

5 December 2017

Salvatore Lobello

4

1 reference

5 December 2017

Maria Chiaramonte

5

1 reference

5 December 2017

Giuseppe Colucci

7

1 reference

5 December 2017

language of work or name

1 reference

1 December 2003

1 reference

5 December 2017

published in

Journal of Hepatology

1 reference

5 December 2017

volume

39

1 reference

5 December 2017

issue

6

1 reference

5 December 2017

page(s)

1036-1041

1 reference

Characteristics of patients with dual infection by hepatitis B and C viruses

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900470-7

7 January 2021

A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900470-7

7 January 2021

Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900470-7

7 January 2021

The long-term course of chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900470-7

7 January 2021

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900470-7

7 January 2021

Prevalence of anti-HCV antibodies in patients with chronic liver disease and its relationship to HBV and HDV infections

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900470-7

7 January 2021

Viral replication in patients with concomitant hepatitis B and C virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900470-7

7 January 2021

Hepatitis C Virus Infection in Chronic Hepatitis B Virus Carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900470-7

7 January 2021

Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900470-7

7 January 2021

Chronic hepatitis D: a vanishing Disease? An Italian multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900470-7

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900470-7

7 January 2021

Classification of chronic viral hepatitis: a need for reassessment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900470-7

7 January 2021

Seroprevalence of hepatitis C markers among intravenous drug users in western European countries: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900470-7

7 January 2021

Hepatitis C virus and blood transfusion: past and present risks

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900470-7

7 January 2021

The disappearance of transfusion-transmitted hepatitis C virus infections in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900470-7

7 January 2021

An estimate of the current risk of transmitting blood-borne infections through blood transfusion in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900470-7

7 January 2021

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900470-7

7 January 2021

Surgical procedures as a major risk factor for chronic hepatitis C virus infection in Italy: evidence from a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900470-7

7 January 2021

Intrafamilial transmission of hepatitis C virus: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900470-7

7 January 2021

Risk of parenterally transmitted hepatitis following exposure to surgery or other invasive procedures: results from the hepatitis surveillance system in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900470-7

7 January 2021

Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900470-7

7 January 2021

Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900470-7

7 January 2021

Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900470-7

7 January 2021

Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900470-7

7 January 2021

Risk factors for hepatocellular carcinoma in Italy. Male sex, hepatitis B virus, non-A non-B infection, and alcohol

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900470-7

7 January 2021

Clinical and virological profiles in patients with multiple hepatitis virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900470-7

7 January 2021

Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900470-7

7 January 2021

State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and -negative liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900470-7

7 January 2021

Natural fluctuations of hepatitis C viral load in a homogeneous patient population: A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900470-7

7 January 2021

Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900470-7

7 January 2021

Clinical course of hepatitis C virus during the first decade of infection: cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900470-7

7 January 2021

Characteristics of hepatocellular carcinoma in Italy.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900470-7

7 January 2021

10.1016/S0168-8278(03)00470-7

Identifiers

DOI

1 reference

5 December 2017

1 reference